Psychiatry - July 2008 - (Page 10) Editorial Advisory Board EDITOR Amir H. Kalali, MD Vice President, Global Therapeutic Group Leader CNS, Quintiles Inc., San Diego, California; Professor of Psychiatry, University of California, San Diego FOUNDING EDITOR Wade H. Berrettini, MD, PhD Karl E. Rickels Professor of Psychiatry, Director, Center for Neurobiology and Behavior, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania PRESIDENT/GROUP PUBLISHER Robert L. Dougherty Matrix Medical Communications Edgemont, Pennsylvania PARTNER Patrick D. Scullin Matrix Medical Communications Edgemont, Pennsylvania VICE PRESIDENT, BUSINESS DEVELOPMENT Joseph J. Morris Matrix Medical Communications Edgemont, Pennsylvania VICE PRESIDENT, EXECUTIVE EDITOR Elizabeth A. Klumpp Matrix Medical Communications Edgemont, Pennsylvania ASSOCIATE EDITOR Colleen M. Hutchinson Matrix Medical Communications Edgemont, Pennsylvania ASSOCIATE EDITOR Kimberly B. Chesky Matrix Medical Communications Edgemont, Pennsylvania NATIONAL SALES MANAGER Brad A. Lacey Matrix Medical Communications Edgemont, Pennsylvania Ahmed Aboraya, MD, DrPH Chief of Psychiatry,William R. Sharpe, Jr. Hospital, Clinical Associate Professor of Psychiatry, West Virginia School of Osteopathic Medicine, Director of World Health Organization (WHO) SCAN Training and Reference Center, West Virginia University, Morgantown, West Virginia A. Ari Albala, MD, DFAPA Clinical Professor of Psychiatry, University of California, San Diego, Medical Director, Psychiatric Centers at San Diego, Clinical Director, Geriatric Psychiatry Program— Aurora Behavioral Health, San Diego, California Per Bech, MD Professor of Psychiatry, Psychiatric Research Unit, Frederiksborg General Hospital, Hillerød, Denmark Thomas C. Benfield, MD Clinical Assistant Professor, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania Robert M. Bilder, PhD, ABPP-CN Professor of Psychiatry and Biobehavioral Sciences and Psychology, Semel Institute for Neuroscience & Human Behavior and David Geffen School of Medicine at UCLA, Los Angeles, California Pierre Blier, MD, PhD Professor of Psychiatry and Cellular & Molecular Medicine, University of Ottawa, Canada Research Chair, Psychopharmacology, Endowed Chair and Director, Mood Disorders Research Unit, Institute of Mental Health Research, Ottawa, Canada Michel S. Bourin, MD, Pharm D Psychiatrist, Professor of Pharmacology, Nantes University, Nantes, France; Adjunct Professor, Department of Psychiatry, Edmonton University, Alberta, Canada; and Visiting Professor, University of Craiova, Romania Peter Buckley, MD Professor and Chairman, Department of Psychiatry, Medical College of Georgia, Augusta, Georgia William E. Bunney, Jr., MD Distinguished Professor and Della Martin Chair of Psychiatry, Department of Psychiatry and Human Behavior, University of California, Irvine, California Joseph R. Calabrese, MD Professor of Psychiatry, Co-Director, Bipolar Disorder Research Center, Case University School of Medicine; Director, Mood Disorders Program, University Hospitals of Cleveland, Cleveland, Ohio Dennis S. Charney, MD Dean, Mount Sinai School of Medicine, Executive Vice President for Academic Affairs, the Mount Sinai Medical Center, Anne and Joel Ehrenkranz Professor, Departments of Psychiatry, Neuroscience, and Pharmacology and Systems Therapeutics, Mount Sinai School of Medicine, New York, New York David L. Copolov, MB BS, PhD, DPM, MPM, FRACP, FRANZCP Senior Advisor, Office of the Vice Chancellor and President and President and Professor of Psychiatry, Monash University, Honorary Professorial Fellow, University of Melbourne, and Research Group Leader, The Mental Health Research Institute of Victoria. Melbourne, Australia Vladimir Coric, Jr., MD Associate Clinical Professor of Psychiatry, Yale OCD Research Clinic; and Director, Global Clinical Research-Neuroscience, BristolMyers Squibb Company, Wallingford, Connecticut Andrew J. Cutler, MD Courtesy Assistant Professor, Department of Psychiatry, University of Florida; President and Medical Director, Florida Clinical Research Center, LLC, Maitland, Florida Robin Emsley, MD Professor and Head, Department of Psychiatry, University of Stellenbosch; Professor and Clinical Head, Department of Psychiatry, Stikland Hospital and Tygerberg Hospital, Cape Town, South Africa Kenneth R. Evans, PhD Department of Psychiatry, University of Toronto, President and CEO, Ontario Cancer Biomarker Network, Toronto, Ontario, Canada David Feifel, MD, PhD Professor in Residence, Department of Psychiatry; Director, Neuropsychiatry and Behavioral Medicine Program; Director, UCSD Adult ADHD Program, University of California, San Diego Medical Center, San Diego, California Timothy W. Fong, MD Assistant Clinical Professor, Director of the Impulse Control Disorders Clinic, Co-Director of the UCLA Gambling Studies Program, Director, UCLA Addiction Psychiatry Fellowship, David Geffen School of Medicine at UCLA, Semel Insitute of Neuroscience and Behavior, Department of Psychiatry and Biobehavioral Sciences, Los Angeles, California Frank G. Fortunati, Jr., MD, JD Assistant Clinical Professor in Psychiatry, Division of Law and Psychiatry, Yale University School of Medicine, New Haven, Connecticut Toshi A. Furukawa, MD, PhD Professor and Chair, Department of Psychiatry and CognitiveBehavioral Medicine, Nagoya City, University Graduate School of Medical Sciences, Mizuho-cho, Mizuho-ku, Nagoya, Japan Julie Gentile, MD Assistant Professor of Psychiatry, Director of Dual Diagnosis Program (Mental Illness/Intellectual Disabilities), Director of Student Mental Health, Wright State University, Department of Psychiatry, Dayton, Ohio Joan B. Gerbasi, JD, MD Private practice of clinical and forensic psychiatry, Davis, California Nassir Ghaemi, MD, MPH Professor of Psychiatry, Director, Mood Disorders and Psychopharmacology Research Programs, Tufts Medical Center, Tufts University, Boston, Massachusetts Paulette M. Gillig, MD, PhD Professor of Psychiatry, Department of Psychiatry, School of Medicine, Wright State University, Dayton, Ohio 10 Psychiatry 2008 [JULY]
Table of Contents Feed for the Digital Edition of Psychiatry - July 2008 Psychiatry - July 2008 Editor's Message Editorial Advisory Board Contents PsychRx Letters to the Editor Reliability of Diagnoses: Do Psychiatrists Use Structured Interviews In Real Clinical Settings? Trend Watch: Use of Atypical Antipsychotics in the Elderly Review: The Struggle for Mental Healthcare in New Orleans-One Case at a Time Psychotherapy Rounds: Psychotherapeutic and Adjuntive Pharmacologic Approaches to Treating Posttraumatic Stress Disorder Original Research: Baseline Dissociation and Prospective Success in Special Forces Assessment and Selection Commentary: Performance-Enhancing Drugs: Where Should the Line Be Drawn and By Whom? Commentary: Psychiatric Diagnosis and the Pathlogist's View of Schizophrenia Journal Watch Classified Advertising Information for Authors Psychiatry - July 2008 Psychiatry - July 2008 - (Page 1) Psychiatry - July 2008 - (Page 2) Psychiatry - July 2008 - (Page 3) Psychiatry - July 2008 - (Page 4) Psychiatry - July 2008 - (Page 5) Psychiatry - July 2008 - (Page 6) Psychiatry - July 2008 - (Page 7) Psychiatry - July 2008 - Editor's Message (Page 8) Psychiatry - July 2008 - Editor's Message (Page 9) Psychiatry - July 2008 - Editorial Advisory Board (Page 10) Psychiatry - July 2008 - Editorial Advisory Board (Page 11) Psychiatry - July 2008 - Contents (Page 12) Psychiatry - July 2008 - Contents (Page 13) Psychiatry - July 2008 - Contents (Page 14) Psychiatry - July 2008 - Contents (Page 15) Psychiatry - July 2008 - PsychRx (Page 16) Psychiatry - July 2008 - PsychRx (Page 17) Psychiatry - July 2008 - PsychRx (Page 18) Psychiatry - July 2008 - PsychRx (Page 23) Psychiatry - July 2008 - Letters to the Editor (Page 24) Psychiatry - July 2008 - Letters to the Editor (Page 25) Psychiatry - July 2008 - Reliability of Diagnoses: Do Psychiatrists Use Structured Interviews In Real Clinical Settings? (Page 26) Psychiatry - July 2008 - Reliability of Diagnoses: Do Psychiatrists Use Structured Interviews In Real Clinical Settings? (Page 27) Psychiatry - July 2008 - Trend Watch: Use of Atypical Antipsychotics in the Elderly (Page 28) Psychiatry - July 2008 - Trend Watch: Use of Atypical Antipsychotics in the Elderly (Page 29) Psychiatry - July 2008 - Trend Watch: Use of Atypical Antipsychotics in the Elderly (Page 30) Psychiatry - July 2008 - Trend Watch: Use of Atypical Antipsychotics in the Elderly (Page 31) Psychiatry - July 2008 - Review: The Struggle for Mental Healthcare in New Orleans-One Case at a Time (Page 32) Psychiatry - July 2008 - Review: The Struggle for Mental Healthcare in New Orleans-One Case at a Time (Page 33) Psychiatry - July 2008 - Review: The Struggle for Mental Healthcare in New Orleans-One Case at a Time (Page 34) Psychiatry - July 2008 - Review: The Struggle for Mental Healthcare in New Orleans-One Case at a Time (Page 35) Psychiatry - July 2008 - Review: The Struggle for Mental Healthcare in New Orleans-One Case at a Time (Page 36) Psychiatry - July 2008 - Review: The Struggle for Mental Healthcare in New Orleans-One Case at a Time (Page 37) Psychiatry - July 2008 - Review: The Struggle for Mental Healthcare in New Orleans-One Case at a Time (Page 38) Psychiatry - July 2008 - Review: The Struggle for Mental Healthcare in New Orleans-One Case at a Time (Page 39) Psychiatry - July 2008 - Review: The Struggle for Mental Healthcare in New Orleans-One Case at a Time (Page 40) Psychiatry - July 2008 - Review: The Struggle for Mental Healthcare in New Orleans-One Case at a Time (Page 41) Psychiatry - July 2008 - Psychotherapy Rounds: Psychotherapeutic and Adjuntive Pharmacologic Approaches to Treating Posttraumatic Stress Disorder (Page 42) Psychiatry - July 2008 - Psychotherapy Rounds: Psychotherapeutic and Adjuntive Pharmacologic Approaches to Treating Posttraumatic Stress Disorder (Page 43) Psychiatry - July 2008 - Psychotherapy Rounds: Psychotherapeutic and Adjuntive Pharmacologic Approaches to Treating Posttraumatic Stress Disorder (Page 44) Psychiatry - July 2008 - Psychotherapy Rounds: Psychotherapeutic and Adjuntive Pharmacologic Approaches to Treating Posttraumatic Stress Disorder (Page 45) Psychiatry - July 2008 - Psychotherapy Rounds: Psychotherapeutic and Adjuntive Pharmacologic Approaches to Treating Posttraumatic Stress Disorder (Page 46) Psychiatry - July 2008 - Psychotherapy Rounds: Psychotherapeutic and Adjuntive Pharmacologic Approaches to Treating Posttraumatic Stress Disorder (Page 47) Psychiatry - July 2008 - Psychotherapy Rounds: Psychotherapeutic and Adjuntive Pharmacologic Approaches to Treating Posttraumatic Stress Disorder (Page 48) Psychiatry - July 2008 - Psychotherapy Rounds: Psychotherapeutic and Adjuntive Pharmacologic Approaches to Treating Posttraumatic Stress Disorder (Page 49) Psychiatry - July 2008 - Psychotherapy Rounds: Psychotherapeutic and Adjuntive Pharmacologic Approaches to Treating Posttraumatic Stress Disorder (Page 50) Psychiatry - July 2008 - Psychotherapy Rounds: Psychotherapeutic and Adjuntive Pharmacologic Approaches to Treating Posttraumatic Stress Disorder (Page 51) Psychiatry - July 2008 - Original Research: Baseline Dissociation and Prospective Success in Special Forces Assessment and Selection (Page 52) Psychiatry - July 2008 - Original Research: Baseline Dissociation and Prospective Success in Special Forces Assessment and Selection (Page 53) Psychiatry - July 2008 - Original Research: Baseline Dissociation and Prospective Success in Special Forces Assessment and Selection (Page 54) Psychiatry - July 2008 - Original Research: Baseline Dissociation and Prospective Success in Special Forces Assessment and Selection (Page 55) Psychiatry - July 2008 - Original Research: Baseline Dissociation and Prospective Success in Special Forces Assessment and Selection (Page 56) Psychiatry - July 2008 - Original Research: Baseline Dissociation and Prospective Success in Special Forces Assessment and Selection (Page 57) Psychiatry - July 2008 - Commentary: Performance-Enhancing Drugs: Where Should the Line Be Drawn and By Whom? (Page 58) Psychiatry - July 2008 - Commentary: Performance-Enhancing Drugs: Where Should the Line Be Drawn and By Whom? (Page 59) Psychiatry - July 2008 - Commentary: Performance-Enhancing Drugs: Where Should the Line Be Drawn and By Whom? (Page 60) Psychiatry - July 2008 - Commentary: Performance-Enhancing Drugs: Where Should the Line Be Drawn and By Whom? (Page 61) Psychiatry - July 2008 - Commentary: Psychiatric Diagnosis and the Pathlogist's View of Schizophrenia (Page 62) Psychiatry - July 2008 - Commentary: Psychiatric Diagnosis and the Pathlogist's View of Schizophrenia (Page 63) Psychiatry - July 2008 - Commentary: Psychiatric Diagnosis and the Pathlogist's View of Schizophrenia (Page 64) Psychiatry - July 2008 - Commentary: Psychiatric Diagnosis and the Pathlogist's View of Schizophrenia (Page 65) Psychiatry - July 2008 - Journal Watch (Page 66) Psychiatry - July 2008 - Journal Watch (Page 67) Psychiatry - July 2008 - Classified Advertising (Page 68) Psychiatry - July 2008 - Information for Authors (Page 69) Psychiatry - July 2008 - Information for Authors (Page 70) Psychiatry - July 2008 - Information for Authors (Page 71) Psychiatry - July 2008 - Information for Authors (Page 72)
For optimal viewing of this digital publication, please enable JavaScript and then refresh the page. If you would like to try to load the digital publication without using Flash Player detection, please click here.